Shukra Pharmaceuticals Ltd

Un-Audited Financial Results Of The Company For The First Quarter Ended June 30 2025 Along With The Auditors Limited Review Reports In Accordance With The Provisions Of Regulation 33 Of The SEBI Listing Regulations.